Diagnostic and Therapeutic Trends in Alzheimer's Disease (Technical Insights)

Diagnostic and Therapeutic Trends in Alzheimer's Disease (Technical Insights)

This research service analyses the latest diagnostic and therapeutic developments that have occurred in the Alzheimer's disease sector, both from a technology and industry perspective.

• Executive summary
  • Research scope and methodology
    • Research scope
    • Research methodology
  • Research highlights
    • Industry overview and key trends
    • Snapshot of noteworthy developments
• Technology primer
  • Alzheimer's disease (ad) overview
    • Ad--a century old pathology
    • Theories in ad--the role of plaques and tangles
    • Disease stages; symptoms; and statistics
  • Alzheimer's disease diagnosis and therapy overview
    • Diagnosis of ad
    • Therapy overview
• Technology intelligence in the ad space
  • Novel mechanism of action drugs--corporate advancements
    • A ‘food drug’ a day may keep alzheimer’s disease away
    • Protecting neurons by targeting cells’ powerhouses
    • Novel neuroprotective therapeutic agents may soon validate 'tau theory' in alzheimer's
    • Steroids mediated clearance of amyloid plaques in alzheimer’s
    • Improving memory by amplifying a novel receptor implicated in neurotransmission
    • A broad portfolio of novel drugs in the pipeline for alzheimer's
  • Ad therapeutics--academic research highlights
    • Study identifies molecule involved in beta-amyloid induced neuron death
    • Vaccine for alzheimer’s triggers a safe immune response and clears amyloid plaques in a mice study
  • Advances in ad diagnosis--corporate and academic efforts
    • Alzheimer’s diagnosis made simple and safe with a novel blood test
    • Advances in in vitro detection of the amyloid plaques in alzheimer’s
    • Computers to the rescue–a novel approach to early ad diagnosis
    • Imaging studies reveal a functional maker implicated in early alzheimer's disease
• Technology adoption factor analysis
  • Force-field analysis
    • The driving forces
    • The restraining forces and challenges
  • Strategic evaluation of the competitive environment
    • A strategic evaluation of ad medication space--swot analysis
    • Strategic assessment of competitive landscape and attractiveness of ad therapeutics sector--world
  • Current and futuretrends; industry roadmap; and strategic recommendations (analyst's perspectives)
    • Roadmap of diagnostic and therapeutic trends in ad sector
    • Strategic recommendations for existing symptomatic drugs
    • Strategic recommendations for disease modifying drugs
• Intellectual property (ip) scenario; key contacts
  • The ip scenario
    • Alzheimer's disease therapeutics--key patents
    • Alzheimer's disease diagnostics--key patents
  • Key contacts
    • Key corporate contacts
    • Key academic contacts
• Decision support database tables
  • Database tables
    • Total healthcare expenditure--world (2002 to 2012)
    • Pharmaceutical r&d expenditure--world (2002 to 2012)
    • Number of physicians--world (2002 to 2012)
    • Number of hospitals--world (2002 to 2012)
    • Number of nurses--world (2002 to 2012)